Engineered HSV for the Treatment of Malignant Glioma - Project 3 - Preclinical Evaluation of Oncolytic HSV for Anaplastic Glioma Therapy

Grant

Date/time Interval

  • July 1, 2009 - June 30, 2015
  • Total Award Amount

  • 966703.00
  • Direct Costs

  • 659989.00
  • Sponsor Award Id

  • 5P01CA071933
  • Contributor

  • George Gillespie   Investigator  
  • James Markert M.D., M.P.H.   Investigator  
  • Richard Whitley M.D.   Principal Investigator